On the other hand, it has been reported that blockade of ATM improves the antitumor effects of sorafenib in HCC cells, with suppression of Akt signaling and significant potentiation of the cytotoxic effects [74, 75]. This evidence concerns the gene ATM and hepatocellular carcinoma.